Tumor-inhibiting ruthenium complexes - Formulation and analytical characterization

Analusis

Volumn 26, Issue 6, 1998, Pages

  Pieper, T ^a   Keppler, B K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; OLIGONUCLEOTIDE; PLASMA PROTEIN; POLYNUCLEOTIDE; RUTHENIUM COMPLEX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG PROTEIN BINDING; DRUG SOLUBILITY; HUMAN;

EID: 0032457067     PISSN: 03654877     EISSN: None     Source Type: Journal    
DOI: 10.1051/analusis:1998155     Document Type: Article

References (9)

1. Keppler, B. K.; Rupp, W.; Juhl, U. M.; Endres, H.; Niebl, R.; Balzer, W. Inorg. Chem. 1987, 26, 4366.
2. Keppler, B. K.; Henn, M.; Juhl, U. M.; Berger, M. R.; Niebl, R.; Wagner, F. E. Progr. Clin. Biochem. Med. 1989, 10, 41.
3. Berger, M. R.; Garzon, F.; Keppler, B. K.; Schmähl, D. Anticancer Res. 1989, 9, 761.
4. Chatlas, J.; van Eldik, R.; Keppler, B. K. Inorg. Chim. Acta 1995, 233, 59.
5. Ni Dhubhghaill, O. M.; Hagen, W. R.; Keppler, B. K.; Lipponer, K. G.; Sadler, P. J. J. Chem. Soc. Dalton Trans. 1994, 3305.
6. Lipponer, K. G.; Vogel, E.; Keppler, B. K. Metal-Based Drugs 1996, 3, 244.
7. Kratz, F.; Hartmann, M.; Keppler, B. K.; Messori, L. J. Biol. Chem. 1994, 269, 2581.
8. Smith, C. A.; Sutherland-Smith, A. J.; Keppler, B. K.; Kratz, F, Baker, E. N. J. Bioinorg. Chem. 1996, 1, 424.
9. Hartmann, M.; Einhäuser, T. J.; Keppler, B. K. Chem. Commun. 1996, 15, 1741.